Form 4: Vivani Medical Director Acquires Stock Options in Lieu of Cash Retainer

Vivani Medical director Daniel Bradbury acquired 50,059 stock options in lieu of a $45,000 cash retainer, according to a recent SEC filing.

Summary

• Daniel Bradbury, a director at Vivani Medical, Inc., acquired 50,059 non-qualified stock options on January 1, 2025.
• These options were granted in lieu of a $45,000 cash retainer fee, as part of the company's non-employee director compensation policy.
• The options have an exercise price of $1.16 per share and a 10-year term, expiring on December 31, 2034.
• The options vest quarterly through December 31, 2025, contingent upon continued service as a director.

Sentiment

Score: 7

Explanation: The document reflects a standard compensation practice, which is generally positive for aligning director interests with shareholders. There are no indications of negative sentiment.

Positives

• The use of stock options in lieu of cash may conserve company cash resources.
• The vesting schedule incentivizes continued service from the director.

Risks

• The value of the stock options is dependent on the future performance of Vivani Medical's stock price.
• If the stock price does not increase above the exercise price, the options may not be valuable to the director.

Industry Context

The use of stock options as part of director compensation is a common practice in the biotechnology industry, aligning director interests with shareholder value creation.

Comparison to Industry Standards

• Many biotechnology companies use stock options as part of their compensation packages for directors and executives.
• The vesting schedule and 10-year term are typical for stock options grants.
• The value of the options is dependent on the company's stock performance, which is a standard practice to align incentives.

Stakeholder Impact

• Shareholders may view the use of stock options positively as it conserves cash and aligns director interests with company performance.
• The director benefits from the potential upside of the stock options.

Key Dates

Keywords

stock options, director compensation, non-qualified stock options, SEC Form 4, Vivani Medical, VANI, equity compensation